IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)
$3.59 -0.05 (-1.3736%)
Analysed IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) News Sources
Immuneering Appoints Andrew Gengos as Chief Financial Officer
15-06-2026
yahoo.com
Immuneering (IMRX) Upgraded to Buy: Here's What You Should Know
15-07-2026
yahoo.com
Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition
21-07-2026
yahoo.com
Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates
05-08-2026
yahoo.com
Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients
26-08-2026
yahoo.com
Immuneering to Participate in Upcoming Investor Conferences
03-09-2026
yahoo.com
Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival
10-09-2026
yahoo.com
Immuneering to Present at the ESMO Congress 2026
24-09-2026
yahoo.com
Immuneering Presents Data at 2026 AACR Conference on Pancreatic Cancer Supporting Atebimetinib’s Mechanisms Designed to Extend Survival in Pancreatic Cancer
28-09-2026
yahoo.com
Immuneering to Present at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
02-10-2026
yahoo.com
What is the current price of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)?
The current price of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) is $3.59.
IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) since the previous trading day is $-0.05.
IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) since the previous trading day is -1.3736%.
What is the most recent average sentiment score for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)?
The most recent average sentiment score for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)?
The most recent sentiment for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) is .
SEC-8K** Filing Available For IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.